EGFR and breast carcinoma: Taken together, these data indicate that alterations in the level of pY374-PKCδ, regulated by the opposing actions of the tyrosine kinase FER and the tyrosine phosphatase PTPN14, modulate EGFR signaling and the growth of breast cancer cells.